dr. borchmann discusses the updated analysis of juliet in dlbcl
Published 6 years ago • 94 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
1:59
dr. borchmann on next steps with tisagenlecleucel in dlbcl
-
1:12
safety data in phase ii juliet trial in dlbcl
-
5:51
updated juliet results for tisagenlecleucel in dlbcl
-
3:08
response data from the juliet trial in dlbcl
-
4:27
car-t gives sustained disease control in r/r adult dlbcl: updated juliet analysis
-
3:46
juliet trial update: myc expression and t-cell responses in r/r dlbcl
-
58:24
update on diffuse large b-cell lymphoma | lrf webinars
-
0:46
dlbcl prognosis & management in front-line settings #oncology #lungcancer #cancer #2023
-
1:16
dr. balzarotti on the challenges of treating elderly dlbcl
-
0:43
summary of two important lymphoma studies - polarix andd swog s1826 #oncology #cancer #lymphoma
-
3:39
the role of novel therapies in r/r dlbcl
-
4:08
utilizing biology to improve on r-chop in dlbcl: targeting ubiquitous markers & mutational analysis
-
2:18
the need for more effective, less toxic therapies in frontline dlbcl treatment
-
1:07
dr. winter discusses the zuma-7 trial in dlbcl
-
1:05
updates on tafasitamab for the treatment of dlbcl
-
0:37
the importance of diagnosing dlbcl on a molecular level and how it will improve treatment
-
4:41
prof. gilles salles: interim analysis of the juliet study of ctl019 in r/r dlbcl
-
2:09
dr. bruce d. cheson describes the lymphoma research foundation
-
4:10
treating relapsed diffuse large b-cell lymphoma